Alset (NASDAQ:AEI - Get Free Report)'s stock had its "sell (d-)" rating reaffirmed by equities research analysts at Weiss Ratings in a research note issued to investors on Friday,Weiss Ratings reports.
Separately, Wall Street Zen raised Alset to a "sell" rating in a research note on Saturday, October 4th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of "Sell".
Read Our Latest Research Report on Alset
Alset Stock Performance
NASDAQ AEI traded up $0.35 during trading on Friday, hitting $2.90. 115,297 shares of the company's stock traded hands, compared to its average volume of 503,708. The stock has a market capitalization of $113.58 million, a price-to-earnings ratio of -2.77 and a beta of 1.41. Alset has a 12-month low of $0.70 and a 12-month high of $4.55. The business has a 50 day moving average of $2.35 and a 200-day moving average of $1.47.
Alset (NASDAQ:AEI - Get Free Report) last issued its quarterly earnings data on Thursday, August 14th. The company reported ($0.71) EPS for the quarter. Alset had a negative return on equity of 14.31% and a negative net margin of 77.86%.The business had revenue of $1.10 million for the quarter.
Insiders Place Their Bets
In other Alset news, CEO Heng Fai Ambrose Chan sold 500,000 shares of the business's stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $2.67, for a total value of $1,335,000.00. Following the completion of the sale, the chief executive officer owned 31,322,903 shares in the company, valued at approximately $83,632,151.01. The trade was a 1.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 62.10% of the company's stock.
Alset Company Profile
(
Get Free Report)
Alset Inc engages in the real estate development, financial services, digital transformation technologies, biohealth activities, and consumer products businesses in the United States, Singapore, Hong Kong, Australia, and South Korea. It operates through four segments: Real Estate, Digital Transformation Technology, Biohealth, and Other Business Activities segments.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Alset, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alset wasn't on the list.
While Alset currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.